SV1999000144A - Procedimientos para preparar sales de trovafloxacina de adicion de acidos ref. pc10011abcz - Google Patents

Procedimientos para preparar sales de trovafloxacina de adicion de acidos ref. pc10011abcz

Info

Publication number
SV1999000144A
SV1999000144A SV1999000144A SV1999000144A SV1999000144A SV 1999000144 A SV1999000144 A SV 1999000144A SV 1999000144 A SV1999000144 A SV 1999000144A SV 1999000144 A SV1999000144 A SV 1999000144A SV 1999000144 A SV1999000144 A SV 1999000144A
Authority
SV
El Salvador
Prior art keywords
acid
salts
addition
trovafloxacin
ref
Prior art date
Application number
SV1999000144A
Other languages
English (en)
Spanish (es)
Inventor
Timothy Norris
Peter Robert Rose
Keith Michael Devries
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SV1999000144A publication Critical patent/SV1999000144A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
SV1999000144A 1998-09-03 1999-09-02 Procedimientos para preparar sales de trovafloxacina de adicion de acidos ref. pc10011abcz SV1999000144A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (1)

Publication Number Publication Date
SV1999000144A true SV1999000144A (es) 2000-09-05

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1999000144A SV1999000144A (es) 1998-09-03 1999-09-02 Procedimientos para preparar sales de trovafloxacina de adicion de acidos ref. pc10011abcz

Country Status (40)

Country Link
US (1) US6359137B1 (enExample)
EP (1) EP0989119A1 (enExample)
JP (1) JP3354526B2 (enExample)
KR (1) KR20000022858A (enExample)
CN (1) CN1248580A (enExample)
AP (1) AP1118A (enExample)
AR (1) AR021475A1 (enExample)
AU (1) AU761035B2 (enExample)
BG (1) BG103703A (enExample)
BR (1) BR9904082A (enExample)
CA (1) CA2281244C (enExample)
CO (1) CO5251466A1 (enExample)
EA (1) EA002340B1 (enExample)
EE (1) EE04118B1 (enExample)
GE (1) GEP20022785B (enExample)
GT (1) GT199900142A (enExample)
HN (1) HN1999000141A (enExample)
HR (1) HRP990274A2 (enExample)
HU (1) HUP9902967A3 (enExample)
ID (1) ID23718A (enExample)
IL (1) IL131614A0 (enExample)
IN (1) IN191583B (enExample)
IS (1) IS5168A (enExample)
MA (1) MA24966A1 (enExample)
MY (1) MY130800A (enExample)
NO (1) NO994261L (enExample)
NZ (1) NZ337605A (enExample)
OA (1) OA11152A (enExample)
PA (1) PA8481001A1 (enExample)
PE (1) PE20001026A1 (enExample)
PL (1) PL335246A1 (enExample)
SG (1) SG74748A1 (enExample)
SK (1) SK116599A3 (enExample)
SV (1) SV1999000144A (enExample)
TN (1) TNSN99164A1 (enExample)
TR (1) TR199902138A2 (enExample)
TW (1) TW520369B (enExample)
UY (1) UY25686A1 (enExample)
YU (1) YU43199A (enExample)
ZA (1) ZA995630B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
CZ286896B6 (en) * 1994-01-18 2000-07-12 Pfizer Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation
DE69503066T2 (de) * 1995-06-06 1998-10-15 Pfizer Inc., New York, N.Y. KRISTALLFORM VON WASSERFREIEN 7-((1a,5a,6a)-6-AMINO-3-AZABICYCLO (3.1.0.) HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDIN-CARBONSÄURE METHANESULFONSÄURE SALZ
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
TR199800339T1 (xx) * 1995-08-29 1998-06-22 Pfizer Inc. Trovafloksasinin melez iyonik bi�imleri.
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates

Also Published As

Publication number Publication date
EA199900708A2 (ru) 2000-04-24
IL131614A0 (en) 2001-01-28
NZ337605A (en) 2001-03-30
BG103703A (bg) 2001-08-31
AP9901667A0 (en) 1999-12-31
JP2000086658A (ja) 2000-03-28
CA2281244C (en) 2003-05-20
US6359137B1 (en) 2002-03-19
JP3354526B2 (ja) 2002-12-09
EA199900708A3 (ru) 2000-08-28
ZA995630B (en) 2001-03-01
NO994261L (no) 2000-03-06
HN1999000141A (es) 2000-06-19
HUP9902967A2 (hu) 2000-05-28
TW520369B (en) 2003-02-11
EE04118B1 (et) 2003-08-15
HU9902967D0 (en) 1999-10-28
UY25686A1 (es) 2000-03-31
MA24966A1 (fr) 2000-04-01
PA8481001A1 (es) 2000-09-29
HUP9902967A3 (en) 2000-11-28
CA2281244A1 (en) 2000-03-03
EE9900457A (et) 2000-04-17
AU4482699A (en) 2000-03-16
IN191583B (enExample) 2003-12-06
AU761035B2 (en) 2003-05-29
MY130800A (en) 2007-07-31
TNSN99164A1 (fr) 2005-11-10
TR199902138A2 (xx) 2000-04-21
KR20000022858A (ko) 2000-04-25
OA11152A (en) 2003-04-17
SG74748A1 (en) 2000-08-22
GT199900142A (es) 2001-02-15
GEP20022785B (en) 2002-09-25
YU43199A (sh) 2002-11-15
HRP990274A2 (en) 2000-10-31
AR021475A1 (es) 2002-07-24
EA002340B1 (ru) 2002-04-25
CO5251466A1 (es) 2003-02-28
PE20001026A1 (es) 2000-10-11
EP0989119A1 (en) 2000-03-29
SK116599A3 (en) 2000-05-16
AP1118A (en) 2002-11-21
IS5168A (is) 2000-03-04
ID23718A (id) 2000-05-11
NO994261D0 (no) 1999-09-02
BR9904082A (pt) 2000-09-12
CN1248580A (zh) 2000-03-29
PL335246A1 (en) 2000-03-13

Similar Documents

Publication Publication Date Title
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
GT200000190A (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas.
BR0308681A (pt) Métodos de fabricação de derivados de ácido beta-hidroxicarboxìlico
PT1252170E (pt) Cristalizacao selectiva do acido 3-piridil-1-hidroxietilideno-1,1-bisfosfonico de sodio como hemipentahidrato ou monohidrato
HN1998000020A (es) Derivados de acido arilsulfonilhidroxamico.
ES2183943T3 (es) Productos intermedios y procedimiento para la fabricacion de derivados de camptotecina (cpt-11) y compuestos relacionados.
ES2193909T3 (es) Procedimiento para la preparacion de esteres de acidos fosfinicos.
CY1107003T1 (el) Μεθοδος παρασκευης οξαζολιδινονων
PA8559401A1 (es) Sales de acido succinico de 5,7,14-triazatetraciclo (10.3.1.0 2,11.0 4, 9)-hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
MXPA03000510A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos.
HN2000000031A (es) Inhibidores de acido abierto y sales de dihidrolixilo de redustosa hmg-co-a.
ES2159488B1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
CU22953A3 (es) Procedimiento para la preparación de ácidos 8-metoxiquinoloncarboxílicos
ES2105217T3 (es) Preparacion de intermedios en la sintesis de antibioticos de quinolina.
PT1097130E (pt) Processo de preparacao do acido hidroximetiltiobutirico
AU2003284326A1 (en) Method for the alkylation of salicylic acid
ES2169481T3 (es) Procedimientos e intermedios utiles para preparar antifolatos.
BRPI0013751B8 (pt) processo para produção de derivados de ácido naftiridina-3-carboxílico.
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
AR035978A1 (es) Proceso para preparar imipenem
PA8481001A1 (es) Procedimiento para preparar sales de trovafloxacina de adicion de acidos
BRPI0017522B8 (pt) processo para preparação de secretagogos de hormônio de crescimento e polimorfo
ES2173399T3 (es) Procedimiento para la sintesis de benzotiofenos.
ECSP993123A (es) Procedimiento para preparar sales de trovafloxacina de adicion de acidos
BR0009886A (pt) Método para a fabricação de ácidos 2-(n-fenilamino) benzóicos

Legal Events

Date Code Title Description
FD Lapse